Literature DB >> 15013040

Immunomodulating effect of antimicrobial agents on cytokine production by human polymorphonuclear neutrophils.

Gigliola Reato1, Anna Maria Cuffini, Vivian Tullio, Narcisa Mandras, Janira Roana, Giuliana Banche, Robin Foa, Nicola A Carlone.   

Abstract

It has been previously demonstrated that some antimicrobial agents enhance activities of human polymorphonuclear neutrophils (PMNs). The effect on the release of cytokines in an inflammatory context from PMNs by these antibiotics was evaluated. We studied the effect of the release of some cytokines by human PMNs RT-PCR analysis on a clinical strain of Klebsiella pneumoniae by comparing the effect with that observed in the presence of co-amoxiclav, sanfetrinem, clarithromycin, prulifloxacin and tobramycin. All the drugs tested were capable of modulating PMN synthesis in vitro of pro-inflammatory cytokines IL-8, IL-1beta, TNF-alpha and IL-6, but not that of anti-inflammatory cytokine IL-10. The degree of their stimulatory or inhibitory potency varied with the cytokine examined.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15013040     DOI: 10.1016/j.ijantimicag.2003.07.006

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  12 in total

1.  Acute renal failure probably induced by prulifloxacin in an elderly woman : a first case report.

Authors:  L Gallelli; A Gallelli; G Vero; F Roccia; G Pelaia; G De Sarro; R Maselli
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

Review 2.  Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis.

Authors:  P M Bartold; A H du Bois; S Gannon; D R Haynes; R S Hirsch
Journal:  Inflammopharmacology       Date:  2013-02-28       Impact factor: 4.473

3.  Why Antibiotic Treatment Is Not Enough for Sepsis Resolution: an Evaluation in an Experimental Animal Model.

Authors:  Jonathan L Halbach; Andrew W Wang; Dennis Hawisher; David M Cauvi; Radhames E Lizardo; Joseph Rosas; Tony Reyes; Omar Escobedo; Stephen W Bickler; Raul Coimbra; Antonio De Maio
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

4.  NK cells in gamma-interferon-deficient mice suppress lung innate immunity against Mycoplasma spp.

Authors:  Matthew D Woolard; Dorothy Hudig; Leslie Tabor; James A Ivey; Jerry W Simecka
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

5.  Phase 2 study of clarithromycin, pomalidomide, and dexamethasone in relapsed or refractory multiple myeloma.

Authors:  Tomer M Mark; Peter A Forsberg; Adriana C Rossi; Roger N Pearse; Karen A Pekle; Arthur Perry; Angelique Boyer; Linda Tegnestam; David Jayabalan; Morton Coleman; Ruben Niesvizky
Journal:  Blood Adv       Date:  2019-02-26

6.  Relationship between azithromycin susceptibility and administration efficacy for nontypeable Haemophilus influenzae respiratory infection.

Authors:  Begoña Euba; Javier Moleres; Cristina Viadas; Montserrat Barberán; Lucía Caballero; María-Jesús Grilló; José Antonio Bengoechea; Juan Pablo de-Torres; Josefina Liñares; José Leiva; Junkal Garmendia
Journal:  Antimicrob Agents Chemother       Date:  2015-02-23       Impact factor: 5.191

7.  Comparison of Azithromycin and Amoxicillin Before Dental Implant Placement: An Exploratory Study of Bioavailability and Resolution of Postoperative Inflammation.

Authors:  Mariana Gil Escalante; Tim D Eubank; Binnaz Leblebicioglu; John D Walters
Journal:  J Periodontol       Date:  2015-08-07       Impact factor: 6.993

Review 8.  Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics.

Authors:  Helen C Steel; Annette J Theron; Riana Cockeran; Ronald Anderson; Charles Feldman
Journal:  Mediators Inflamm       Date:  2012-06-21       Impact factor: 4.711

Review 9.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 10.  Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis.

Authors:  Francesco Blasi; Stefano Aliberti; Paolo Tarsia; PierAchille Santus; Stefano Centanni; Luigi Allegra
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.